Health
India’s drug controller approves phase 2, 3 human trials of COVID-19 vaccine – China.org.cn
NEW DELHI, Aug. 3 (Xinhua) — Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) to conduct phase 2 and 3 human clinical trials of COVID-19 vaccine developed by Oxford University, officials said Monday.
“The DCGI has given approval to SII, Pune to conduct Phase II and III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine (COVISHIELD) in India. This will hasten the development of the COVID-19 vaccine,” a statement issued by country’s fed…
-
Noosa News17 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General17 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
General15 hours agoIncreased police powers begin at Adelaide Oval Ashes Test following Bondi attacks
-
General22 hours agoDe-escalation skills, not guards, needed in Tasmanian hospitals, nurses’ union says